2015
Brada M, Pope A, Baumann (2015) SABR in NSCLC - The beginning of the end or the end of the beginning? Radiother Oncol 114: 135–137
Budach V, Stromberger C, Poettgen C, Baumann M, Budach W, Grabenbauer G, Marnitz S, Olze H, Wernecke K-D, Ghadjar P (2015) Hyperfractionated Accelerated Radiation Therapy (HART) of 70.6 Gy With Concurrent 5-FU/Mitomycin C Is Superior to HART of 77.6 Gy Alone in Locally Advanced Head and Neck Cancer: Long-term Results of the ARO 95-06 Randomized Phase III Trial. Int J Radiat Oncol Biol Phys 91: 916–924
De Ryck T, Van Impe A, Vanhoecke BW, Heyerick A, Vakaet L, De Neve W, Müller D, Schmidt M, Dörr W, Bracke ME (2015) 8-prenylnaringenin and tamoxifen inhibit the shedding of irradiated epithelial cells and increase the latency period of radiation-induced oral mucositis: Cell culture and murine model. Strahlenther Onkol 191: 429–436
Dietrich A, Koi L, Zöphel K, Sihver W, Kotzerke J, Baumann M, Krause M (2015) Improving external beam radiotherapy by combination with internal irradiation. Br J Radiol 20150042
Eke I, Zscheppang K, Dickreuter E, Hickmann L, Mazzeo E, Unger K, Krause M, Cordes N (2015). Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer. J Natl Cancer Inst 107
Gruber S, Schmidt M, Bozsaky E, Wolfram K, Haagen J, Habelt B, Puttrich M, Dörr W (2014) Modulation of radiation-induced oral mucositis by pentoxifylline: Preclinical studies. Strahlenther Onkol
Gruber S, Hamedinger D, Bozsaky E, Schmidt M, Wolfram K, Haagen J, Habelt B, Puttrich M, Dörr W (2015) Local hypoxia in oral mucosa (mouse) during daily fractionated irradiation - Effect of pentoxifylline. Radiother Oncol
Jaffray DA, Atun R, Barton M, Baumann M, Gospodarowicz M, Hoskin P, Knaul FM, Lievens Y, Rosenblatt E, Torode J, van Dyk J, Vikram B, on behalf of the Union for International Cancer Control´s Global Task Force on Radiotherapy for Cancer Control (2015) Radiation therapy and the global health agenda. Clin Oncol (R Coll Radiol) 27: 67–69
Jakobi A, Bandurska-Luque A, Stützer K, Haase R, Löck S, Wack L-J, Mönnich D, Thorwarth D, Perez D, Lühr A, Zips D, Krause M, Baumann M, Perrin R, Richter C (2015) Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup NTCP analysis. Int J Radiat Oncol Biol Phys
Jentsch C, Beuthien-Baumann B, Troost EGC, Shakirin G (2015) Validation of functional imaging as a biomarker for radiation treatment response. Br J Radiol 20150014
Krause M, Supiot S (2015) Advances in Radiotherapy special feature. Br J Radiol 20150412
Krause M, Petersen C, Offersen B, Baumann M (2015) Regional radiotherapy in high-risk breast cancer: Is the issue solved? Br J Radiol 20150071
Kriegs M, Gurtner K, Can Y, Brammer I, Rieckmann T, Oertel R, Wysocki M, Dorniok F, Gal A, Grob TJ, Laban S, Kasten-Pisula U, Petersen C, Baumann M, Krause M, Dikomey E (2015) Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest. Radiother Oncol
Löck S, Roth K, Skripcak T, Worbs M, Helmbrecht S, Jakobi A, Just U, Krause M, Baumann M, Enghardt W, Lühr A (2015) Implementation of a software for REmote COMparison of PARticlE and photon treatment plans: ReCompare. Z Med Phys
Menegakis A, von Neubeck C, Yaromina A, Thames H, Hering S, Hennenlotter J, Scharpf M, Noell S, Krause M, Zips D, Baumann M (2015) γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material. Radiother Oncol
Von Neubeck C, Geniza MJ, Kauer PM, Robinson RJ, Chrisler WB, Sowa MB (2015) The effect of low dose ionizing radiation on homeostasis and functional integrity in an organotypic human skin model. Mutat Res 775: 10–18
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, Kirova YM, Pignol J-P, Remouchamps V, Verhoeven K,Weltens C, Arenas M, Gbrys D, Kopek N, Krause M, Lundstedt D Marinko T, Montero A, Yarnold J, Portmans P (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114: 3–10
Oppelt M, Baumann M, Bergmann R, Beyreuther E, Brüchner K, Hartmann J, Karsch L, Krause M, Laschinsky L, Leßmann E, Nicolai M, Reuter M, Richter C, Sävert A, Schnell M, Schürer M, Woithe J, Kaluza M, Pawelke J (2015) Comparison study of in vivo dose response to laser-driven versus conventional electron beam. Radiat Environ Biophys 54: 155–166
Patties I, Haagen J, Dörr W, Hildebrandt G, Glasow A (2015) Late inflammatory and thrombotic changes in irradiated hearts of C57BL/6 wild-type and atherosclerosis-prone ApoE-deficient mice. Strahlenther Onkol 191: 172–179
2014
Baumann M, Overgaard J (2014) What next? Radiother Oncol 110: 1–2
Brüchner K, Beyreuther E, Baumann M, Krause M, Oppelt M, Pawelke J (2014) Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles. Radiat Oncol 9: 57
Bütof R, Kirchner K, Appold S, Löck S, Rolle A, Höffken G, Krause M, Baumann M (2014) Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol 190: 263–269
Dörr W, Herrmann T, Baumann M (2014) Application of organ tolerance dose-constraints in clinical studies in radiation oncology. Strahlenther Onkol 190: 621–627
Dörr W, Kallfels S, Herrmann T (2014) Response to the letter to the editor by Genc et al. Strahlenther Onkol 190: 963–964
Eke I, Ingargiola M, Förster C, Kunz-Schughart LA, Baumann M, Runge R, Freudenberg R, Kotzerke J, Heldt J-M, Pietzsch H-J, Steinbach J, Cordes N (2014) Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro. Int J Radiat Biol 90: 678–686
Gurtner K, Ebert N, Pfitzmann D, Eicheler W, Zips D, Baumann M, Krause M (2014) Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. Radiat Oncol 9: 261
Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Baumann M, Zips D, Yaromina A (2014) BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. Radiat Oncol 9: 207
Helbig L, Koi L, Brüchner K, Gurtner K, Hess-Stumpp H, Unterschemmann K, Pruschy M, Baumann M, Yaromina A, Zips D (2014) Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation. Int J Radiat Oncol Biol Phys 88: 159–166
Ingargiola M, Runge R, Heldt J-M, Freudenberg R, Steinbach J, Cordes N, Baumann M, Kotzerke J, Brockhoff G, Kunz-Schughart LA (2014) Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay. Int J Cancer 135: 968–980
Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Antratschke N, Guckenberger M (2014) Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88: 732–738
Koi L, Bergmann R, Brüchner K, Pietzsch J, Pietzsch H-J, Krause M, Steinbach J, Zips D, Baumann M (2014) Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential. Radiother Oncol 110: 362–369
Krause M, Baumann M (2014) Reduced acute toxicity for adults with medulloblastoma treated with proton beam craniospinal irradiation. Strahlenther Onkol 190: 111–112
Linge A, Maurya P, Friedrich K, Baretton GB, Kelly S, Henry M, Clynes M, Larkin A, Meleady P (2014) Identification and functional validation of RAD23B as a potential protein in human breast cancer progression. J Proteome Res 13: 3212–3222
Lühr A, Löck S, Roth K, Helmbrecht S, Jakobi A, Petersen JB, Just U, Krause M, Enghardt W, Baumann M (2014) Concept for individualized patient allocation: ReCompare--remote comparison of particle and photon treatment plans. Radiat Oncol 9: 59
Monceau V, Llach A, Azria D, Bridier A, Petit B, Mazevet M, Strup-Perrot C, To T-H-V, Calmels L, Germaini M-M, Gourgou S, Fenoglietto P, Bourgier C, Gomez A-M, Escoubet B, Dörr W, Haagen J, Deutsch E, Moret E, Vozenin MC (2014) Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis. Radiother Oncol 111: 63–71
Patties I, Habelt B, Rosin B, Dörr W, Hildebrandt G, Glasow A (2014) Late effects of local irradiation on the expression of inflammatory markers in the Arteria saphena of C57BL/6 wild-type and ApoE-knockout mice. Radiat Environ Biophys 53: 117–124
Philipp J, Baumann M (2014) Caution with hypofractionated dose-escalating radiotherapy in non-small cell lung cancer. Strahlenther Onkol 190: 597–599
Pirkkanen J, von Neubeck C, Sowa M (2014) Summary of an integrated experimental and computational approach to study the effects of heavy ion exposures on skin. NasaTHREE
Ramaekers BLT, Joore MA, Lueza B, Bonastre J, Mauguen A, Pignon J-P, Le Pechoux C, De Ruysscher DKM, MAR-LC Collaborative group, Grutters JPC (2013) Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients. J Thorac Oncol 8: 1295–1307
Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, Drumea K, Dunning AM, Easton D, Eeles R, Fachal L, Gutiérrez-Enríquez S, Haustermans K, Henrúques-Hernándezb LA, Imai T, Jones GDD, Kerns SL, Liao Z, Onel K, Ostrer H, Parliament M, Pharoah PDP, Rebbeck TR, Talbot CJ, Thierens H, Vega A, Witte JS, Wong P, Zenhausern F, for The Radiogenomics Consortium (2014) Radiogenomics: radiobiology enters the era of big data and team science. Int J Radiat Oncol Biol Phys 89: 709–713
Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M (2015) Stereotactic body radiotherapy for centrally located stage I NSCLC : A multicenter analysis. Strahlenther Onkol 191: 125–132
Schmidt M, Haagen J, Noack R, Siegemund A, Gabriel P, Dörr W (2014) Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation. Strahlenther Onkol 190: 399–404
Schmidt M, Piro-Hussong A, Siegemund A, Gabriel P, Dörr W (2014). Modification of radiation-induced oral mucositis (mouse) by adult stem cell therapy: single-dose irradiation. Radiat Environ Biophys 53: 629–634
Schütze C, Bergmann R, Brüchner K, Mosch B, Yaromina A, Zips D, Hessel F, Krause M, Thames H, Kotzerke J, Steinbach J, Baumann M, Beuthien-Baumann B (2014) Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice. Radiother Oncol 111: 81–87
Seidel N, Stoelzel F, Garzarolli M, Herrmann S, Breitbart EW, Berth H, Baumann M, Ehninger G (2013) Sun protection training based on a theater play for preschoolers: an effective method for imparting knowledge on sun protection? J Cancer Educ 28: 435–438
Sihver W, Pietzsch J, Krause M, Baumann M, Steinbach J, Pietzsch H-J (2014) Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy. Pharmaceuticals (Basel) 7: 311–338
Skripcak T, Belka C, Bosch W, Brink C, Brunner T, Budach V, Büttner D, Debus J, Dekker A, Grau C, Gulliford S, Hurkmans C, Just U, Krause M, Lambin P, Langendijk JA, Lewensohn R, Lühr A, Maingon P, Masucci M, Niyazi M, Poortmans P, Simon M, Schmidberger H, Spezi E, Stuschke M, Valentini V, Verheij M, Whitfield G, Zackrisson B, Zips D, Baumann M (2014) Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets. Radiother Oncol 113: 303–309
Stölzel F, Seidel N, Uhmann S, Baumann M, Berth H, Hoyer J, Ehninger G (2014) Be smart against cancer! A school-based program covering cancer-related risk behavior. BMC Public Health 14: 392
Tillner F, Thute P, Bütof R, Krause M, Enghardt W (2014) Preclinical research in small animals using radiotherapy technology - a bidirectional translational approach. Z Med Phys
Wang M, Kern AM, Hülskötter M, Greninger P, Singh A, Pan Y, Chowdhury D, Krause M, Baumann M, Benes CH, Efstathiou J, Settleman J, Willers H (2014) EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation. Cancer Res 74: 2825–2834
2013
Eke I, Schneider L, Krause M, Baumann M, Förster C, Ingargiola M, Kunz-Schughart LA, Cordes N (2013) JNK2 activation via EGFR-JIP-4 protein complex perturbs Cetuximab-mediated radiosensitization of human squamous cell carcinoma cells. Cancer Res 73: 297-306
Soliman M, Yaromina A, Appold S, Zips D, Reiffenstuhl C, Schreiber A, Thames HD, Krause M, Baumann M (2013) GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: Subgroup analysis of the prospective randomized CHARTWEL trial. Radiother Oncol 106: 229-304
Eke I, Storch K, Krause M, Cordes N (2013) Cetuximab attenuates its cytotoxic and radiosensitizing potential by inducing fibronectin biosynthesis in non-small cell lung cancer, Cancer Res 73: 5869-5879
Koch U, Höhne K, von Neubeck C, Thames HD, Yaromina A, Dahm-Daphi J, Baumann M*, Krause M* (*shared last authorship) (2013) Residual gH2AX foci predict local tumour control after radiotherapy. Radiother Oncol 108: 434-439
Krause M, Kummer B, Deparade A, Eicheler W, Pfitzmann D, Yaromina A, Kunz-Schughart L, Baumann M (2013) Simultaneous PLK1 inhibition improves local tumour control after fractionated irradiation. Radiother Oncol 108: 422-428
Abramyuk A, Appold S, Zöphel K, Baumann M, Abolmaali N (2013) Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy. Strahlenther Onkol 189: 197-201
Baumann M, Budach V, Molls M (2013) Zum Gedenken an Prof. Dr. Kian Ang. Strahlenther Oncol 189: 907
Baumann M, Bodis S, Dikomey E, van der Kogel A, Overgaard J, Rodemann HP, Wouters B (2013) Molecular radiation biology/oncology at its best: cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. Radiother Oncol. 108:357-361
Bütof R, Baumann M (2013) Time in radiation oncology - keep it short! Radiother Oncol 106: 271-275.
Bütof R, Dubrovska A, Baumann M (2013) Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol 108: 388-396
Cordes N, Gurtner K, Belka C (2013) Verbesserte Behandlungschancen durch molekulares Targenting in der Radioonkologie. Onkologe: 848-857
Dietrich A, Stewart J, Huether M, Helm M, Schuetze C, Schnittler HJ, Jaffray DA, Kunz-Schughart LA (2013) Macromolecule extravasation-xenograft size matters: a systematic study using probe-based confocal laser endomicroscopy (pCLE). Mol Imaging Biol 15: 693-702
Dubois L, Peeters SG, van Kuijk SJ, Yaromina A, Lieuwes NG, Saraya R, Biemans R, Rami M, Parvathaneni NK, Vullo D, Vooijs M, Supuran CT, Winum JY, Lambin P (2013) Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother Oncol 108: 523-528
Fietkau R, Lewitzki V, Kuhnt T, Hölscher T, Hess CF, Berger B, Wiegel T, Rödel C, Niewald M, Hermann RM, Lubgan D (2013) A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial. Cancer 119: 3343-3353
Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N (2013) Safety and efficacy of stereotactic body radiotherapy for stage i non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis. J Thorac Oncol 8: 1050-1058
Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M (2013) Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 109: 13-20
Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P (2013) Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Int J Radiat Oncol Biol Phys 87: 534-541
Zeil K, Baumann M, Beyreuther E, Burris-Mog T, Cowan TE, Enghardt W, Karsch L, Kraft SD, Laschinsky L, Metzkes J, Naumburger D, Oppelt D, Richter C, Sauerbrey R, Schuerer M, Schramm U, Pawelke J (2013) Dose controlled irradiation of cancer cells with laser accelerated proton pulses. Appl Phys B 110: 437-444
Zips D, Baumann M (2013) Place of proton radiotherapy in future radiotherapy practice. Semin Radiat Oncol 23: 149-153
2012
Schürer M, Baumann M, Beyreuther E, Brüchner K, Enghardt W, Kaluza M, Karsch L, Laschinsky L, Leßmann E, Nicolai M, Oppelt M, Reuter M, Richter C, Sävert A, Schnell M, Woithe J, Pawelke J (2012) Irradiation system for pre-clinical studies with laser accelerated electrons. Biomed Tech 57: 62-65
Saki M, Toulany M, Sihver W, Zenker M, Heldt JM, Mosch B, Pietzsch HJ, Baumann M, Steinbach J, Rodemann HP (2012) Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro. Strahlenther Onkol 188: 823-832
Gurtner K, Hessel F, Eicheler W, Dörfler A, Zips D, Heider KH, Krause M, Baumann M (2012) Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo. Radiother Oncol 102: 444-449
Eke I, Deuse Y, Hehlgans S, Krause M, Baumann M, Shevchenko A, Cordes N (2012). beta1 integrin-FAK-Cortactin signaling essential for head and neck cancer radioresistance. J Clin Invest 122: 1529-1540
Yaromina A, Krause M, Baumann M (2012) Individualization of cancer treatment from radiotherapy perspective. Mol Oncol 6: 211-221
Singer A, Deuse Y, Koch U, Hölscher T, Pfitzmann D, Jakob C, Hehlgans S, Baretton GB, Rentsch A, Baumann M, Muders MH, Krause M (2012) Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer. Strahlenther Onkol 188: 1125-1132
Baumann M, Zips D, Krause M (2012) Experimentelle Tumortherapie. Strahlenther Onkol 188 Suppl 3: 291-294.
Kast K, Krause M, Schuler M, Friedrich K, Thamm B, Bier A, Distler W, Krüger S (2012) Late onset Li-Fraumeni syndrome with bilateral breast cancer and other malignancies: case report and review of the literature. BMC Cancer 12: 21
Mansour W, Bogdanova N, Kasten-Pisula U, Rieckmann T, Koecher S, Borgmann K, Baumann M, Krause M, Petersen C, Hu H, Gatti RA, Dikomey E, Dörk T, Dahm-Daphi J (2012) Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma. Radiother Oncol 106: 147-154
Andreassen CN, Barnett GC, Langendijk JA, Alsner J, De Ruysscher D, Krause M, Bentzen SM, Haviland JS, Griffin C, Poortmans P and Yarnold J on behalf of the ESTRO GENEPI network (2012) Conducting radiogenomic research – do not forget careful consideration of the clinical data. Radiother Oncol 105: 337-340
Yaromina A, Meyer S, Fabian C, Zaleska K, Sattler UG, Kunz-Schughart LA, Mueller-Klieser W, Zips D, Baumann M (2012) Effects of three modifiers of glycolysis on ATP, lactate, hypoxia, and growth in human tumor cell lines in vivo. Strahlenther Onkol 188: 431-437
Helbig L, Yaromina A, Sriramareddy SN, Böke S, Koi L, Thames HD, Baumann M, Zips D (2012) Prognostic value of HIF-1α expression during fractionated irradiation. Strahlenther Onkol 188: 1031-1037
Brunner TB, Kunz-Schughart LA, Grosse-Gehling P, Baumann M (2012) Cancer stem cells as a predictive factor in radiotherapy. Semin Radiat Oncol 22:151-174
Bayer C, Kielow A, Schilling D, Maftei CA, Zips D, Yaromina A, Baumann M, Molls M, Multhoff G (2012) Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation. Int J Radiat Oncol Biol Phys 84: e409-e417
Laschinsky L, Baumann M, Beyreuther E, Enghardt W, Kaluza M, Karsch L, Lessmann E, Naumburger D, Nicolai M, Richter C, Sauerbrey R, Schlenvoigt HP, Pawelke J. (2012) Radiobiological effectiveness of laser accelerated electrons in comparison to electron beams from a conventional linear accelerator. J Radiat Res. 53: 395-403
Mazzeo E, Hehlgans S, Valentini V, Baumann M, Cordes N. (2012) The impact of cell-cell contact, e-cadherin and EGF receptor on the cellular radiosensitivity of A431 cancer cells. Radiat Res 178: 224-233
Abramyuk A, Appold S, Zöphel K, Hietschold V, Baumann M, Abolmaali N. (2012) Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy - A retrospective study. Lung Cancer 78: 148-152
Peickert S, Waurig J, Dittfeld C, Dietrich A, Garbe Y, Kabus L, Baumann M, Grade M, Ried T, Kunz-Schughart LA. (2012) Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo. Lab Invest 92: 1607-1622
Mauguen A, Le Péchoux C, Saunders MI, Schild SE, Turrisi AT, Baumann M, Sause WT, Ball D, Belani CP, Bonner JA, Zajusz A, Dahlberg SE, Nankivell M, Mandrekar SJ, Paulus R, Behrendt K, Koch R, Bishop JF, Dische S, Arriagada R, De Ruysscher D, Pignon JP (2012) Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol 30: 2788-2797
Saki M, Toulany M, Sihver W, Zenker M, Heldt JM, Mosch B, Pietzsch HJ, Baumann M, Steinbach J, Rodemann HP (2012). Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro. Strahlenther Onkol 188: 823-832
Ingargiola M, Dittfeld C, Runge R, Zenker M, Heldt JM, Steinbach J, Cordes N, Baumann M, Kotzerke J, Kunz-Schughart LA (2012) Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation. Cytometry A 81: 865-873
Zips D, Zöphel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, Appold S, Steinbach J, Kotzerke J, Baumann M (2012). Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol 105: 21-28
